RBC starts Teladoc (NYSE:TDOC) at Outperform and a $100 target. The company has a Very Bullish average Sell Side rating.
Analyst Sean Dodge says awareness and comfort with telehealth is near a “tipping point,” and Teladoc is the market leader.
Dodge sees 25% organic revenue growth over at least the next three years, driven by “new member adds, cross-selling and ramping utilization.”
TDOC shares are up 1% pre-market to $78.30.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.